Stem cell therapy and regenerative medicine

Mayo Clinic Proceedings

Volumn 84, Issue 10, 2009, Pages 859-861

  O'Brien, Timothy ^a   Barry, Frank P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; FRACTURE NONUNION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOPHOSPHATASIA; ISCHEMIC HEART DISEASE; NONHUMAN; OSTEOGENESIS IMPERFECTA; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; BONE REGENERATION; HEART DISEASE; METABOLIC BONE DISEASE; NOTE;

BONE DISEASES, METABOLIC; BONE REGENERATION; HEART DISEASES; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 70350482212     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.10.859     Document Type: Editorial

References (15)

1. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009;84(10):876-892.
2. Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc. 2009;84(10):893-902.
3. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008 Aug;29(15):1807-1818. Epub 2008 Jun 3.
4. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007 Oct 30;50(18):1761-1767. Epub 2007 Oct 15. (Pubitemid 47600592)
5. + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30(11):1313-1321.
6. Schächinger V, Erbs S, Elsässer A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355(12):1210-1221. (Pubitemid 44427445)
7. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006; 355(12):1199-1209. (Pubitemid 44427444)
8. Mareschi K, Ferrero I, Rustichelli D, et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem. 2006;97(4):744-754.
9. Izadpanah R, Kaushal D, Kriedt C, et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008; 68(11):4229-4238.
10. Mylotte LA, Duffy AM, Murphy M, et al. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells. 2008 May;26(5):1325-1336. Epub 2008 Feb 28.
11. Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007 Sep;25(9):2350-2357. Epub 2007 May 24. (Pubitemid 47480494)
12. Li W, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007 Aug;25(8):2118-2127. Epub 2007 May 3. (Pubitemid 47258191)
13. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7(4):430-436.
14. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204-1219.
15. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872. (Pubitemid 350138099)